Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, ESTA, TNL, IMAX, CDXS, and represent 46.01% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$158M), AMPH (+$36M), PTON (+$34M), SYK (+$18M), PAYA (+$17M), ATGE (+$15M), DRI (+$13M), SMLR (+$11M), RMR (+$10M), FTVI (+$9.8M).
- Started 26 new stock positions in ALEC, AURA, DRI, FTVIW, ONTF, STIM, ATGE, SYK, HLGN, AMYT.
- Reduced shares in these 10 stocks: TLT (-$87M), W (-$86M), , , CAR (-$64M), CVNA (-$61M), , , SGMS (-$26M), .
- Sold out of its positions in ACAD, ACET, Athena Technology Acquisition, ATXI, CAR, BRPMU, CRBU, CVNA, Dover Motorsports, EXAS.
- Nantahala Capital Management was a net seller of stock by $-377M.
- Nantahala Capital Management has $2.3B in assets under management (AUM), dropping by -28.77%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nantahala Capital Management
Companies in the Nantahala Capital Management portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf (IWM) | 27.9 | $630M | +33% | 3.1M | 205.27 | |
| Establishment Labs Holdings Ord (ESTA) | 6.4 | $145M | +4% | 2.1M | 67.39 | |
| Travel Leisure Ord (TNL) | 4.6 | $104M | -7% | 1.8M | 57.94 | |
| Imax Corp Cad (IMAX) | 4.1 | $92M | +5% | 4.9M | 18.93 | |
| Codexis (CDXS) | 3.1 | $70M | -9% | 3.4M | 20.62 | |
| Scientific Games (SGMS) | 3.0 | $67M | -27% | 1.1M | 58.75 | |
| Uniqure Nv SHS (QURE) | 3.0 | $67M | -4% | 3.7M | 18.07 | |
| Herman Miller (MLKN) | 2.5 | $56M | +10% | 1.6M | 34.56 | |
| Travelcenters Of America Com New (TA) | 2.4 | $55M | 1.3M | 42.96 | ||
| Meta Financial (CASH) | 2.1 | $48M | -24% | 870k | 54.92 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $47M | 2.7M | 17.38 | ||
| Keros Therapeutics (KROS) | 2.1 | $47M | +12% | 859k | 54.38 | |
| Golden Entmt (GDEN) | 1.8 | $40M | -23% | 691k | 58.07 | |
| Peloton Interactive Cl A Com (PTON) | 1.7 | $39M | +639% | 1.5M | 26.42 | |
Setup an alertNantahala Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Luxfer Holdings SHS (LXFR) | 1.7 | $38M | +5% | 2.2M | 16.80 | |
| Red Violet (RDVT) | 1.6 | $36M | +26% | 1.3M | 28.50 | |
| Amphastar Pharmaceuticals Put Option (AMPH) | 1.6 | $36M | NEW | 1.0M | 35.90 | |
| Dxp Enterprises Com New (DXPE) | 1.4 | $32M | 1.2M | 27.09 | ||
| Rmr Group Cl A (RMR) | 1.3 | $30M | +53% | 962k | 31.10 | |
| International Money Express (IMXI) | 1.3 | $29M | -7% | 1.4M | 20.61 | |
| Paya Holdings Com Cl A (PAYA) | 1.1 | $26M | +197% | 4.4M | 5.86 | |
| Immatics SHS (IMTX) | 1.0 | $24M | +11% | 2.9M | 7.99 | |
| Dhi (DHX) | 1.0 | $23M | +13% | 3.8M | 5.95 | |
| Apollo Endosurgery (APEN) | 1.0 | $23M | +48% | 3.7M | 6.05 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 1.0 | $23M | -50% | 250k | 89.88 | |
| Alta Equipment Group Common Stock (ALTG) | 1.0 | $22M | -6% | 1.8M | 12.36 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.8 | $18M | +47% | 4.3M | 4.17 | |
| Stryker Corporation Put Option (SYK) | 0.8 | $18M | NEW | 68k | 267.36 | |
| Semler Scientific (SMLR) | 0.8 | $18M | +145% | 357k | 49.56 | |
| Adtalem Global Ed Put Option (ATGE) | 0.7 | $15M | NEW | 500k | 29.71 | |
| Bbq Hldgs (BBQ) | 0.6 | $14M | -4% | 952k | 15.14 | |
| Reading Intl Cl A (RDI) | 0.6 | $14M | -7% | 3.2M | 4.28 | |
| Darden Restaurants Put Option (DRI) | 0.6 | $13M | NEW | 100k | 132.95 | |
| Fortress Biotech (FBIO) | 0.5 | $12M | +8% | 8.8M | 1.36 | |
| Cue Biopharma (CUE) | 0.5 | $11M | -12% | 2.2M | 4.88 | |
| Dariohealth Corp Com New (DRIO) | 0.4 | $10M | +61% | 1.7M | 5.84 | |
| Aptose Biosciences Com New (APTO) | 0.4 | $10M | 7.3M | 1.36 | ||
| Fintech Acquisition Corp Vi Class A Com (FTVI) | 0.4 | $9.8M | NEW | 1000k | 9.82 | |
| Insu Acquisition Corp Iii Com Cl A (IIII) | 0.4 | $9.8M | 995k | 9.82 | ||
| Fintech Acquisition Corp V Com Cl A (FTCV) | 0.4 | $9.5M | -3% | 958k | 9.87 | |
| Hca Holdings (HCA) | 0.4 | $8.9M | 36k | 250.62 | ||
| Amryt Pharma Sponsored Ads (AMYT) | 0.4 | $8.9M | NEW | 1.1M | 8.27 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.4 | $8.7M | +6% | 1.3M | 6.52 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs (ARYE) | 0.4 | $8.4M | -13% | 866k | 9.73 | |
| Shift Technologies Cl A (SFT) | 0.4 | $8.2M | -16% | 3.7M | 2.20 | |
| Herbalife Nutrition Com Shs Call Option (HLF) | 0.4 | $8.1M | -3% | 268k | 30.36 | |
| Ftac Hera Acquisition Corp Class A Ord Shs (HERA) | 0.3 | $7.8M | -19% | 800k | 9.79 | |
| Scully Royalty Com Shs (SRL) | 0.3 | $7.6M | +2% | 772k | 9.82 | |
| Aeglea Biotherapeutics (AGLE) | 0.3 | $7.4M | +110% | 3.2M | 2.30 | |
| Mediaalpha Cl A (MAX) | 0.3 | $7.2M | NEW | 438k | 16.55 | |
| Par Technology Corp Note 2.875% 4/1 (Principal) | 0.3 | $7.0M | -3% | 5.8M | 1.20 | |
| Strata Skin Sciences Com New (SSKN) | 0.3 | $6.7M | 4.6M | 1.47 | ||
| Aura Biosciences (AURA) | 0.3 | $6.6M | NEW | 302k | 22.00 | |
| Viemed Healthcare (VMD) | 0.3 | $6.4M | -9% | 1.3M | 4.98 | |
| Akumin (AKU) | 0.3 | $6.2M | -11% | 5.6M | 1.11 | |
| Curis Com New (CRIS) | 0.3 | $5.9M | 2.5M | 2.38 | ||
| Cymabay Therapeutics (CBAY) | 0.3 | $5.9M | NEW | 1.9M | 3.11 | |
| B. Riley Financial (RILY) | 0.2 | $5.5M | -16% | 79k | 69.95 | |
| On24 (ONTF) | 0.2 | $5.1M | NEW | 384k | 13.15 | |
| Avalo Therapeutics (AVTX) | 0.2 | $4.8M | 6.8M | 0.70 | ||
| Perella Weinberg Partners Class A Com (PWP) | 0.2 | $4.7M | +4% | 503k | 9.45 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.2 | $4.1M | NEW | 5.0M | 0.83 | |
| Vroom Call Option (VRM) | 0.2 | $4.0M | NEW | 1.5M | 2.66 | |
| Neuropace (NPCE) | 0.2 | $4.0M | +242% | 485k | 8.21 | |
| Nautilus Biotechnology (NAUT) | 0.2 | $3.9M | -14% | 894k | 4.34 | |
| Kura Oncology Call Option (KURA) | 0.2 | $3.9M | NEW | 241k | 16.08 | |
| Wayfair Cl A (W) | 0.2 | $3.8M | -95% | 35k | 110.79 | |
| Heliogen Common Stock (HLGN) | 0.1 | $3.4M | NEW | 644k | 5.26 | |
| Merrimack Pharmaceuticals In Com New (MACK) | 0.1 | $3.3M | -9% | 517k | 6.33 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $3.2M | -18% | 326k | 9.80 | |
| Silverback Therapeutics (SBTX) | 0.1 | $3.2M | -25% | 914k | 3.45 | |
| B Riley Principal 150 Merger Com Cl A (BRPM) | 0.1 | $3.0M | NEW | 302k | 9.92 | |
| Neuronetics (STIM) | 0.1 | $2.7M | NEW | 880k | 3.03 | |
| Imv (IMV) | 0.1 | $2.6M | -17% | 1.9M | 1.41 | |
| Angion Biomedica Corp (ANGN) | 0.1 | $2.5M | +889% | 1.2M | 2.12 | |
| Imac Hldgs (IMAC) | 0.1 | $2.3M | -7% | 2.2M | 1.03 | |
| Acer Therapeutics (ACER) | 0.1 | $2.3M | -14% | 778k | 2.90 | |
| Zovio (ZVO) | 0.1 | $2.1M | -12% | 2.6M | 0.82 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $2.1M | NEW | 597k | 3.54 | |
| Soleno Therapeutics Com New (SLNO) | 0.1 | $2.1M | -3% | 9.4M | 0.22 | |
| Idw Media Hldgs CL B (IDW) | 0.1 | $2.0M | -9% | 1.1M | 1.83 | |
| Faraday Futre Intlgt Elctr I (FFIE) | 0.1 | $1.7M | 350k | 4.99 | ||
| Immatics *w Exp 07/01/202 (IMTXW) | 0.1 | $1.7M | +357% | 1.0M | 1.68 | |
| Payoneer Global (PAYO) | 0.1 | $1.7M | -41% | 385k | 4.46 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $1.6M | -17% | 819k | 2.00 | |
| 5 01 Acquisition Corp Com Cl A (FVAM) | 0.1 | $1.6M | -12% | 162k | 9.85 | |
| Catalyst Biosciences Com New (CBIO) | 0.1 | $1.6M | 2.4M | 0.66 | ||
| Lava Therapeutics Nv SHS (LVTX) | 0.1 | $1.5M | -9% | 334k | 4.40 | |
| Metromile (MILE) | 0.1 | $1.4M | -45% | 1.0M | 1.32 | |
| Alector (ALEC) | 0.1 | $1.4M | NEW | 95k | 14.25 | |
| Exagen (XGN) | 0.1 | $1.3M | -24% | 159k | 8.03 | |
| In8bio (INAB) | 0.1 | $1.2M | -5% | 353k | 3.48 | |
| Lucid Diagnostics (LUCD) | 0.0 | $1.1M | NEW | 315k | 3.36 | |
| Wejo Group Common Shares (WEJO) | 0.0 | $857k | NEW | 215k | 3.99 | |
| Unicycive Therapeutics (UNCY) | 0.0 | $826k | -8% | 641k | 1.29 | |
| Perella Weinberg Partners *w Exp 12/31/202 (PWPPW) | 0.0 | $822k | +2% | 409k | 2.01 | |
| Tango Therapeutics (TNGX) | 0.0 | $749k | 99k | 7.58 | ||
| Akebia Therapeutics Call Option (AKBA) | 0.0 | $693k | -80% | 966k | 0.72 | |
| Cognition Therapeutics (CGTX) | 0.0 | $540k | NEW | 196k | 2.75 | |
| TransAct Technologies Incorporated (TACT) | 0.0 | $504k | -6% | 71k | 7.07 | |
| Eloxx Pharmaceuticals (ELOX) | 0.0 | $434k | -35% | 775k | 0.56 | |
| Galmed Pharmaceuticals SHS (GLMD) | 0.0 | $412k | -30% | 259k | 1.59 | |
| Htg Molecular Diagnostics In Com New (HTGM) | 0.0 | $397k | -17% | 286k | 1.39 | |
| Fintech Acquisition Corp V *w Exp 12/31/202 (FTCVW) | 0.0 | $317k | 333k | 0.95 | ||
| Kintara Therapeutics (KTRA) | 0.0 | $264k | 663k | 0.40 | ||
| Falcon Minerals Corp *w Exp 07/21/202 (FLMNW) | 0.0 | $256k | -23% | 675k | 0.38 | |
| Fintech Acquisition Corp Vi *w Exp 03/31/202 (FTVIW) | 0.0 | $143k | NEW | 250k | 0.57 | |
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $142k | -37% | 374k | 0.38 | |
| Tc Biopharm Holdings *w Exp 02/08/202 | 0.0 | $117k | NEW | 235k | 0.50 | |
| B Riley Principal 150 Merger *w Exp 03/01/202 (BRPMW) | 0.0 | $109k | NEW | 121k | 0.90 | |
| Ftac Hera Acquisition Corp *w Exp 02/28/202 (HERAW) | 0.0 | $97k | -10% | 223k | 0.44 | |
| Insu Acquisition Corp Iii *w Exp 12/31/202 (IIIIW) | 0.0 | $67k | 333k | 0.20 | ||
| Metromile *w Exp 02/09/202 (MILEW) | 0.0 | $66k | -9% | 508k | 0.13 | |
| Qualtek Services *w Exp 02/14/202 | 0.0 | $56k | NEW | 96k | 0.58 | |
| Ocugen (OCGN) | 0.0 | $55k | NEW | 17k | 3.32 | |
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2022 Q1 filed May 13, 2022
- Nantahala Capital Management 2021 Q3 filed Nov. 15, 2021
- Nantahala Capital Management 2021 Q2 filed Aug. 16, 2021
- Nantahala Capital Management 2021 Q1 filed May 14, 2021
- Nantahala Capital Management 2020 Q4 filed Feb. 16, 2021
- Nantahala Capital Management 2020 Q3 filed Nov. 16, 2020
- Nantahala Capital Management 2020 Q2 filed Aug. 14, 2020
- Nantahala Capital Management 2020 Q1 filed May 14, 2020
- Nantahala Capital Management 2019 Q4 filed Feb. 14, 2020
- Nantahala Capital Management 2019 Q3 filed Nov. 14, 2019
- Nantahala Capital Management 2019 Q2 filed Aug. 14, 2019
- Nantahala Capital Management 2019 Q1 filed May 15, 2019
- Nantahala Capital Management 2018 Q4 filed Feb. 14, 2019
- Nantahala Capital Management 2018 Q3 filed Nov. 14, 2018
- Nantahala Capital Management 2018 Q2 filed Aug. 14, 2018
- Nantahala Capital Management 2018 Q1 filed May 15, 2018